AMDA’s Drive to Deprescribe (D2D) initiative put practitioners behind the wheel on medication optimization. During a recent AMDA On-The-Go podcast, guest host Jennifer Pruskowski, PharmD, MS, BCPS, BCGP, CPE, sat down with Michael Steinman, MD, co-director of the U.S. Deprescribing Research Network, to tal...
To describe and validate the Post-acute Delayed Discharge Risk Scale (PADDRS), which classifies patients by risk of delayed discharge on admission to post-acute care settings using information collected with the interRAI Minimum Data Set (MDS) 2.0 assessment.